4.5 Review

Central serous chorioretinopathy: An update on risk factors, pathophysiology and imaging modalities

期刊

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.preteyeres.2020.100865

关键词

Central serous chorioretinopathy (CSC); Choroid; Retinal pigment epithelium (RPE); Corticosteroids; Choroidal endothelial cells (CECs); Complement factor H (CFH); Pachychoroid; Hyperpermeability; Mineralocorticoids; Eplerenone

资金

  1. NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust
  2. UCL Institute of Ophthalmology
  3. NIHR
  4. GCRF UKRI [MR/P207881/1]

向作者/读者索取更多资源

Central serous chorioretinopathy (CSC) is a common form of vision loss, typically seen in working-age men. The pathophysiology behind CSC still eludes us, however significant advances have been made in understanding this disease over the last decade using information from genetic and cell-based studies and imaging modalities. This review aims to give an overview of the current pathophysiology hypotheses surrounding CSC in addition to future directions in cellular work from human induced pluripotent stem cell derived choroidal endothelial cells from CSC patients. Furthermore, this review will provide the reader with an update on the clinical aspects of CSC including risk factors, diagnostic challenges and findings from multimodal imaging.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据